View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Obinutuzumab 1000 / Zanubrutinib 160 / Venetoclax (20/50/100/200), Chronic Lymphocytic Leukemia, Cycle 3
Protocol-ID: 2639 V1.0 (Mini), OBIN1000/ZANU160/VNTC(20/50/100/200), CLL, C3Indication(s)
- Chronic Lymphocytic Leukemia / Small Lymphocytic Lymphoma; ICD-10 C91.1-
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 13.06.2024